Free Trial
NASDAQ:CMPS

COMPASS Pathways Q1 2025 Earnings Report

COMPASS Pathways logo
$3.98 +0.21 (+5.57%)
As of 04:00 PM Eastern

COMPASS Pathways EPS Results

Actual EPS
N/A
Consensus EPS
-$0.47
Beat/Miss
N/A
One Year Ago EPS
N/A

COMPASS Pathways Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

COMPASS Pathways Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Thursday, May 8, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

COMPASS Pathways Earnings Headlines

Analysts Set COMPASS Pathways plc (NASDAQ:CMPS) Target Price at $20.20
"I'm risking my reputation on this"
I've discovered something so significant about the 2025 crypto market that I had to put everything else aside and write a book about it. This isn't just another Bitcoin prediction – it's a complete roadmap for what I believe will be the biggest wealth-building opportunity of this decade. The evidence is so compelling, I'm doing something that probably seems insane: I'm giving away my entire book for free.
See More COMPASS Pathways Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like COMPASS Pathways? Sign up for Earnings360's daily newsletter to receive timely earnings updates on COMPASS Pathways and other key companies, straight to your email.

About COMPASS Pathways

COMPASS Pathways (NASDAQ:CMPS) operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

View COMPASS Pathways Profile

More Earnings Resources from MarketBeat